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Calyculin A, a protein phosphatase inhibitor wtth a chemical structure completely different from that of okadaic acid, reproduced the inhibttory 
effect of okadatc acid on cychc AMP-mediated amylase release from rat parotid acmar cells. Calyculin A markedly enhanced phosphorylation of 
cytokeratins in the cytoskeletal fraction of the cells. whereas CAMP had apparently no effect on the phosphorylation. Microscopic observations 
showed that parotid acini incubated with 100 nM calyculin A for 15 min had large vacuoles in the cytoplasm and conspicuous blebs on the basal 
plasma membrane. K252a, a nonselecttve protein kinase inhibitor, clearly reduced calyclin A-induced phosphorylation of cytokeratins. and it 
markedly blocked the mhtbition of amylase release and morphological changes evoked by calyculin A. These results suggest that hyperphosphoryla- 
tton of cytokeratins profoundly affects the morphology and secretory acttvity of parotid acmar cells. 
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1. INTRODUCTION 
Protein phosphorylation has been generally thought 
to play a central role in the regulatory mechanisms of 
diverse cellular functions [1,2]. In the regulation of ex- 
ocytosis, however, the role of protein phosphorylation 
has yet to be established, although almost all secretory 
stimuli affect protein phosphorylation [3,4]. Amylase 
exocytosis from parotid acinar cells has been extensively 
studied as a useful model of CAMP-mediated exocytosis 
[3,5]. Several lines of evidence support the involvement 
of CAMP-dependent protein kinase in amylase exocyto- 
sis [6-S]. Nevertheless, previous studies using protein 
kinase inhibitors (H-8 and peptide fragments of heat- 
stable protein kinase inhibitor) suggested that CAMP- 
dependent protein phosphorylation was not directly in- 
volved in the exocytosis, since the inhibitors markedly 
inhibited protein phosphorylation without decreasing 
amylase release [6,9]. Furthermore, okadaic acid, a po- 
tent selective inhibitor of protein phosphatase types 1 
and 2A, increased protein phosphorylation but inhib- 
ited, rather than enhanced, CAMP-mediated amylase 
release [lo]. 
Recently okadaic acid and its related protein phos- 
phatase inhibitors have been found to provoke hyper- 
phosphorylation of vimentin, a cytoskeletal protein of 
intermediate filaments, in human and mouse fibroblasts 
[11,12]. Although it has long been postulated that cy- 
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toskeletal proteins play important roles in the process 
of exocytosis [13-161, the relationship between phos- 
phorylation states of cytoskeletal proteins and amylase 
exocytosis has not been examined so far. Thus, for the 
first time, we have studied the effects of CAMP and 
protein phosphatase inhibitors on the phosphorylation 
of cytoskeletal proteins in rat parotid acini. 
2. EXPERIMENTAL 
2.1. Muterials 
Okadaic acid was generous gift from Dr. Y. Tsukitani (Fujisawa 
Pharmaceutical, Tokyo, Japan). Calyculin A and K252a were pur- 
chased from Wako Pure Chemicals (Osaka, Japan) and Kyowa Medex 
(Tokyo), respectively. [y-‘*P]ATP was from DuPont-Daiichi (Tokyo). 
Monoclonal antibodies to cytokeratins and actin were from Labsys- 
terns Japan (Tokyo) and Amersham Japan (Tokyo), respectively. All 
other reagents were of the highest grade commercially available. 
2.2. Amnylase release 
Parotid acini were prepared by enzyme digestion, and amylase re- 
lease from intact and saponin-permeabthzed acmi was measured as 
described [6,8]. 
2.3. Phosphor$ation of cytoskeletal proteins 
Parotid acmi were premcubated for 5 mm at 37°C with 20 pg/ml 
saponin. - 0.2 mCt/ml [y-“P]ATP m Ca-free medium composed of 
120 mM KCI, 40 mM K-HEPES (pH 7.2). 1 mM EGTA, 2 mM 
MgC12. 1 mg/ml bovine serum albumin, and 10 @ml Phenol red and 
further Incubated for 15 min after addition of calycuhn A and/or 
CAMP After incubation, the medium was removed and the cells were 
homogenized m 0.3 M sucrose, 10 mM K-phosphate (pH 6.8), 10 mM 
EDTA. and 5 mM EGTA in a Teflon-glass homogenizer. For prepa- 
ration of the cytoskeletal fraction, the homogenates were treated at 
4°C for 10 mm wtth 1% Triton X-100.0.6 M KCI, 10 mM EDTA, and 
10 mM K-phosphate (pH 6.8) washed twice with the same medium 
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and twice wtth the homogenizing medium as above. and the resulting 
pellets were boiled for 10 mm in 3% SDS, 5% 2-mercaptoethanol. 10% 
glycerol, and 70 mM Tris-HCl (pH 6.8). 
2.4. Itnttunoblottv~g anti ittatlunoprrcipitatlott 
Protems in the cytoskeletal fracttons were separated by SDS-PAGE 
usmg 10% running gel and 4% stackmg gel, and were transferred to 
a polyvinylidene difluoride (PVDF) membrane. Cytokeratms and 
actm on the membrane uere immunologtcally identified by the avtdin 
btottnperoxidase complex method using mouse monoclonal anttbod- 
ies to cytokeratms and actin as the first antibodies. 
The cytoskeletal proteins were solubilized by bothng for 10 mm wrth 
3% SDS. 10 mM HEPES-Trts (pH 7.2). 0.14 M NaCl. 1% Trtton 
X-l 00. and 1 mM EDTA, and were diluted to 0.1% SDS with the same 
solutton without SDS. Ahquots of the solubtlized proteins were incu- 
bated with anti-cytokeratin anttbody and protein A sepharose. The 
immunoprectpitate was separated by SDS-PAGE, and cytokeratms 
were detected by autoradiography. 
Parotrd acim were fixed with 2% glutaraldehyde m 0.1 M Na- 
cacodylate buffer (pH 7.4) contaimng 0.2% tanmc acid for 1 h at 4°C. 
and post-fixed vvtth 1% 0~0, m disttlled water for 30 min at room 
temperature. The preparations were dehydrated with acetone and 
embedded m Spurr resin. One-micrometer sections were cut and 
stained with 1% Tolmdine blue. 
3. RESULTS 
Fig. 1 shows the ffect of calyculin A, a potent inhib- 
itor of protein phosphatase types 1 and 2A [17], on 
amylase release from intact parotid acini. Calyculin A 
strongly inhibited amylase release stimulated by lo? 
and lo-’ M isoproterenol, the maximum and half-max- 
imum doses, respectively. In contrast, calyculin A alone 
slightly increased amylase release. The inhibitory and 
stimulatory effects were clearly observed at 0.1 ,uM ca- 
lyculin A, indicating this drug to be 10 times more po- 
tent than okadaic acid [lo]. The inhibitory effect of 
calyculin A was similarly observed in saponin-permea- 
bilized parotid acini incubated with exogenous CAMP 
(Fig. 2) suggesting that the inhibition is not due to 
damage to the plasma membrane or P-receptoradenyl- 
ate cyclase system. In this experiment. the lo-fold differ- 
ence in the potency of the two inhibitors was clearly 
confirmed. Since these protein phosphatase inhibitors 
apparently enhance basal activities of all protein kinases 
in the cell, we examined the effect of K252a. a nonselec- 
tive protein kinase inhibitor. Fig. 3 shows that 0.333 ,uM 
K252a dose-dependently blocked the inhibitory effect 
of 100 nM calyculin A on CAMP-mediated amylase 
release. 
Next we examined the effects of CAMP and calyculin 
A on the phosphorylation states of cytoskeletal proteins 
in the 1% Triton X-100 insoluble fraction of parotid 
acini. The fraction contained three major protein bands 
between 40 and 60 kDa, and the upper two bands were 
heavily phosphorylated by 100 nM calyculin A (Fig. 4). 
Immunoblotting studies using monoclonal antibodies 
against cytokeratins and actin revealed that the upper 
two phosphorylated proteins were very likely to be cy- 
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Fig. 1. Effect of calyculin A on amylase release from Intact parotid 
acim. Rat parottd acim were incubated at 37°C for 15 min m regular 
Hanks’ balanced salt solutron containmg vartous concentratrons of 
calycuhn A and 0.0.01. or 1 PM tsoproterenol (ISO). Data shown are 
means + S.D (n = 4). 
tokeratins and the third band was actin (Fig. 5A). Since 
the parotid acini appeared to contain some minor cy- 
tokeratin subunits besides the two major cytokeratin 
bands (Fig. 5A, lane 2). cytokeratins were further char- 
acterized by immunoprecipitation, Fig. 5B shows that 
the anti-cytokeratin antibody clearly precipitated the 
two phosphoproteins. As shown in Fig. 6, 3 ,uM K252a 
markedly inhibited the phosphorylation of cytokeratins 
induced by 100 nM calyculin A. K252a also reduced 
basal phosphorylation of cytokeratins. 
Finally we examined the effect of calyculin A on the 
morphological structure of parotid acini. For that pur- 
pose, we incubated intact acini with 100 nM calyculin 
A and/or 1 ,uM isoproterenol for 15 min. As seen in Fig. 
7, calyculin A induced drastic changes in the cell struc- 
ture; large vacuoles were observed in the cytoplasm and 
conspicuous blebs appeared on the surface of the basal 
plasma membrane (photos 3 and 4 in Fig. 7). Although 
small blebs were occasionally seen in control acini, iso- 
proterenol treatment did not increase their size (photos 
1 and 2). Okadaic acid (1 PM) also -induced similar 
morphological changes in the acini (data not shown). 
K252a (3 PM) had apparently no effect on the morphol- 
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ogy of parotid acini, but clearly prevented the morpho- 
logical changes induced by 100 nM calyculin A (photos 
5 and 6). During these experiments, we monitored the 
leakage of lactic dehydrogenase (LDH) as an index of 
damage to the plasma membrane by calyculin A; ca- 
lyculin A slightly increased LDH leakage from the con- 
trol value of 2.5 + 0.2 (% of the total activity in homo- 
genates) to 4.3 f 0.3% at 100 nM calyculin A during a 
15-min incubation. 
4. DISCUSSION 
The present study revealed that calyculin A clearly 
reproduced the effect of okadaic acid on amylase exocy- 
tosis from parotid acini: strong inhibition of CAMP- 
mediated amylase release and weak stimulation by it- 
self. The dual effects were detectable above lo-’ M ca- 
lyculin A, indicating that calyculin A is 10 times as 
potent as okadaic acid [lo]. Since the two compounds 
share only biological activity but not the same chemical 
structure, it is highly possible that the effects of ca- 
lyculin A and okadaic acid on amylase release are pro- 
voked by the inhibition of protein phosphatases, which 
in turn increases protein phosphorylation. This hypoth- 
esis was strongly supported by the fact that K252a 
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Ftg. 2. Effects of calycuhn A and okadaic acid on amylase release from 
saponin-permeabilized parotid acini. The acini were incubated for 15 
min with 1 mM CAMP and various concentrattons of calyculin A (CA) 
or okadaic actd (OA) m Ca-free KC1 medium containing 20 &ml 
saponm. Data shown are means & S.D. (n = 6). 
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Fig. 3. Effects of calyculm A and K252a on amylase release from 
saponin-permeabthzed parotid acmi. The acini were incubated for 15 
min wtth 1 mM CAMP, 100 nM calyculin A, and various concentra- 
tions of K252a m Ca-free medium containing 20 fig/ml saponm. Data 
shown are means + SD. (n = 6). 
blocked the inhibitory effect of calyculin A. The small 
increase in amylase release by the protein phosphatase 
inhibitors suggests that at least a limited portion of the 
exocytosis depends upon increase in protein phospho- 
rylation. 
The lo-fold difference between the effects of calyculin 
A and okadaic acid indicates that the inhibition of pro- 
tein phosphatase type 1 is a rate-limiting step for the 
present phenomena, since the inhibitory effects of the 
two compounds on protein phosphatase type 2A are 
almost identical (IC,, = 0.5-l nM), while the IC,, of 
calyculin A for type 1 phosphatase is approximately 100 
times lower than that of okadaic acid [17]. In this study, 
however, we could not detect any effect of calyculin A 
up to 10 nM, although its IC,O for type 1 phosphatase 
is 2 nM. This discrepancy may be due to the fact that 
the IC,, values were determined in a cell-free system 
using purified enzymes and substrates; whereas in intact 
and even in permeabilized acini, nonspecific adsorption 
and diffusion barriers decrease accessibility of these 
compounds to protein phosphatases, and such hin- 
drances are especially critical for lower concentrations 
of the reagents. In addition, it has been reported that the 
cellular concentration of protein phosphatases is much 
147 
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Fig. 4. Effects of calyculin A and CAMP on protein phosphorylation in the cytoskeletal fraction of parotid acini. Proteins were separated by 
SDS-PAGE (C20% gradient gel). and phosphorylated proteins were detected by autoradiography. (Left) The gel stamed with Coomassie blue. 
(Right) The autoradiogram. Lane 1, control: lane 2, 100 nM calyculin A; lane 3, I mM cAMP, lane 4, calyculm A plus CAMP. M, molecular markers. 
Arrows and the arrowheads Indicate the major protem bands. 
higher than the IC,, values of calyculin A for those 
phosphatases [ 181. 
In the present study calyculin A strongly enhanced 1 a 3 4 
A 
12 3 
Fig. 5. (A) Western blotting analysis of the cytoskeletal proteins. Lane 
1. the gel stained with Coomassie blue; lanes 2 and 3. the membranes 
incubated with monoclonal anti-cytokeratin and anti-actin antibodies. 
respecttvely. Arrowheads indicate the phosphorylation bands induced 
by calycuhn A. (B) Immunoprecipitation of cytokeratms. Autoradi- 
ograms were preparated from SDS-PAGE ( 10%). Lane 1, protems m 
the cytoskeletal fraction; lanes 2 and 3, immunoprecipitates with con- 
trol and anti-cytokeratin antibodies. respectively. 
Fig. 6. Effects of K252a and calyculin A on protein phosphorylation 
m the cytoskeletal fraction of parotid acini. Proteins were separated 
by SDS-PAGE (5520% gradient get). and phosphorylated protems 
were detected by autoradtography. Lane I. control; lane 2, 3 ,uM 
K252a; lane 3, 100 nM calyculin A; lane 4. 3 PM K252a plus 100 nM 
calyculin A. Arrows indicate positions of the major cytokeratin bands. 
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Fig. 7. Effect of calyculin A on the morphology of parotid acini. (1) Control: (2) 1 ,uM isoproterenol; (3) 100 nM calyculin A; (4) 1 PM isoproterenol 
plus 100 nM calyculin A; (5) 3 ,uM K252a; (6) 3 ,uM K252a plus 100 nM calyculin A. Simple arrows (in photo 2) show acinar lumina as they appear 
during exocytosis. Bars = 20 pm. 
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phosphorylation of cytokeratins in the 1% Triton X- 
insoluble fraction of parotid acinar cells. In contrast, 
CAMP had apparently no effect on protein phosphoryl- 
ation in the cytoskeletal fraction, suggesting that the 
phosphorylation of cytokeratins is not involved in the 
normal process of CAMP-mediated amylase exocytosis. 
It has been amply demonstrated that the phosphoryla- 
tion states of nonhelical terminal domains of intermedi- 
ate filament proteins, including those of vimentin, 
desmin, and lamins, regulate the assembly and disas- 
sembly of these filaments [19-211. Furthermore, hyper- 
phosphorylation of cytokeratins has also been observed 
concurrently with reorganization of cytokeratin fila- 
ments in various cells [32-351 and in a cell-free system 
[36]. In this study K252a clearly inhibited both hyper- 
phosphorylation of cytokeratins and morphological 
changes induced by calyculin A. Thus, the hyper- 
phosphorylation of cytokeratins is very likely to be in- 
volved in the morphological changes seen in the parotid 
acini. 
Previously, cytochalasin D. a microfilament-disrupt- 
ing agent, inhibited amylase release and induced similar 
vacuoles in the rat parotid acini as seen in this study 
[14,15]. When acini were incubated with cytochalasin D 
and isoproterenol, however, the number of secretory 
granules decreased and the vacuoles were filled with 
secretory materials. Thus. it is recognized that the vacu- 
oles are formed by enlargement of acinar lumina or 
intercellular canaliculi. and that the disruption of mi- 
crofilaments itself does not inhibit exocytosis [14.15]. In 
contrast, even when acini were incubated with iso- 
proterenol and calyculin A for 30 min. the vacuoles 
were not filled with the secretory materials. Further- 
more, the origins of the vacuoles produced by calyculin 
A and cytochalasin D are obviously different. since pro- 
tein phosphatase inhibitors induced cytoplasmic vacu- 
oles in various types of single cells [13,27]. In addition, 
it has been well documented that colchicine, a microtu- 
bule- disrupting agent, does not inhibit amylase exocy- 
tosis from parotid glands stimulated by isoproterenol 
[13,28]. Taken together, these findings suggest that the 
reorganization of intermediate filaments induced by hy- 
perphosphorylation of cytokeratins causes more harm- 
ful effects on CAMP-mediated amylase exocytosis than 
the disruption of microfilaments and microtubules. 
Further study is necessary to elucidate the precise role 
of intermediate filaments in exocytosis. 
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